Gilead Sciences announced the voluntary recall of COVID-19 antiviral medication Veklury (remdesivir) after finding the presence of a glass particle in one of the medicine vials.
After receiving a customer complaint, the company investigated the incident and confirmed the presence of the particle, according to a recall notice published on Sept. 20 by the U.S. Food and Drug Administration (FDA). Veklury is used to treat COVID-19. The injections treat adults and pediatric patients (birth to less than 18 years of age weighing at least 1.5 kg or about 3.3 lbs). The patients can be hospitalized or have mild-to-moderate COVID-19 with a high risk for progression to severe disease.
